AMGEN

Filed a patent for "methods and assemblies for efficiently packing pharmaceutical products" on Tue, August 22, 2023

Filed a patent for "compositions comprising cross-species-specific antibodies and uses thereof" on Thu, February 27, 2025

Filed a patent for "methods for reducing yellow color" on Mon, August 14, 2023

Filed a patent for "methods of using carfilzomib" on Wed, August 9, 2023

Filed a patent for "method for equilibrating a chromatography medium" on Fri, July 28, 2023

Filed a patent for "systems, methods, and user interfaces for providing a form map" on Wed, August 9, 2023

Filed a patent for "modifications of peptide compositions to increase stability and delivery efficiency" on Thu, January 30, 2025

Filed a patent for "alternating recirculating tangential flow (artf) filtration for cell culture media perfusion and bioreactor harvesting" on Tue, July 11, 2023

Filed a patent for "vectors incorporating a combination of promoters driving selectable marker expression" on Fri, July 21, 2023

Filed a patent for "isolation of therapeutic protein" on Mon, February 5, 2024

Filed a patent for "t cell engager molecules and uses thereof" on Fri, December 1, 2023

Filed a patent for "charge pair mutations to enable correct heavy-light chain pairing" on Tue, June 27, 2023

Filed a patent for "cellular assays to quantify target-independent clearance of therapeutic proteins" on Wed, June 28, 2023

Filed a patent for "cellular assays to quantify target-independent clearance of therapeutic molecules" on Fri, November 3, 2023

Filed a patent for "lymphotoxin beta receptor agonist binding proteins" on Mon, June 12, 2023

Filed a patent for "bispecific t cell engager masking molecules" on Wed, June 14, 2023

Filed a patent for "methods and systems for determining an impact of attributes" on Thu, June 22, 2023

Filed a patent for "product quality attribute target ranges" on Thu, June 22, 2023

Filed a patent for "t cell engager masking molecules" on Wed, May 15, 2024

Filed a patent for "rnai constructs for inhibiting ttr expression and methods of use thereof" on Fri, December 16, 2022

Filed a patent for "cancer treatments using mta-cooperative prmt5 inhibitors" on Wed, December 21, 2022

Filed a patent for "system and method for analyzing antibody co-formulations" on Mon, January 30, 2023

Filed a patent for "cell culture methods" on Fri, February 3, 2023

Filed a patent for "methods of monitoring surfactant hydrolysis in biopharmaceutical formulations" on Mon, February 6, 2023

Filed a patent for "c-kit binding proteins, chimeric antigen receptors, and uses thereof" on Tue, February 21, 2023